Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA
College of Medicine, Central Michigan University, Mount Pleasant, Michigan, USA.
J Neurointerv Surg. 2024 Jan 12;16(2):209-212. doi: 10.1136/jnis-2023-020374.
Federal research funding is highly sought after but may be challenging to attain. A clear understanding of funding for specific diseases, such as cerebrovascular disorders, might help researchers regarding which National Institutes of Health (NIH) institutes fund research into specific disorders and grant types.
To examine the current scope of NIH grant funding for cerebrovascular conditions.
The NIH-developed RePORTER was used to extract active NIH-funded studies related to cerebrovascular diseases through January 2023. Duplicate studies were removed, and projects were manually screened and labeled in subcategories as clinical and basic science and as research subcategories. Extracted data included total funding, grant types, institutions that received funding, and diseases studied. Python (version 3.9) and SciPy library were used for statistical analyses.
We identified 1232 cerebrovascular projects across seven diseases with US$699 952 926 in total funding. The cerebrovascular diseases with the greatest number of grants were ischemic stroke (705, or 57.2% of all funded projects), carotid disease (193, or 15.7%), and hemorrhagic stroke (163, or 13.2%). R01 grants were the most common mechanism of funding (632 grants, or 51.3%). The National Institute of Neurological Disorders and Stroke (NINDS) funded the most projects (504 projects; US$325 536 405), followed by the National Heart, Lung, and Blood Institute (NHLBI) (376 projects; US$216 784 546).
Cerebrovascular disease receives roughly US$700 million in NIH funding. Ischemic stroke accounts for the majority of NIH-funded cerebrovascular projects, and R01 grants are the most common funding mechanism. Notably, NHLBI provides a large proportion of funding, in addition to NINDS.
联邦研究资金备受追捧，但获得资金可能具有挑战性。清楚了解特定疾病（如脑血管疾病）的资金情况，可能有助于研究人员了解哪些国立卫生研究院 (NIH) 研究所为特定疾病的研究提供资金以及提供哪些资助类型。
检查 NIH 脑血管疾病资助的当前范围。
使用 NIH 开发的 RePORTER 提取截至 2023 年 1 月与脑血管疾病相关的活跃 NIH 资助研究。删除重复的研究，然后手动筛选项目并按子类别（临床和基础科学以及研究子类别）进行标记。提取的数据包括总资金、资助类型、获得资助的机构以及研究的疾病。使用 Python（版本 3.9）和 SciPy 库进行统计分析。
我们确定了 7 种疾病的 1232 个脑血管项目，总资金为 699 952 926 美元。获得资助项目最多的脑血管疾病是缺血性中风（705 个，占所有资助项目的 57.2%）、颈动脉疾病（193 个，占 15.7%）和出血性中风（163 个，占 13.2%）。R01 资助是最常见的资助机制（632 项资助，占 51.3%）。国立神经病学与中风研究所 (NINDS) 资助的项目最多（504 个项目；325 536 405 美元），其次是国家心肺血液研究所 (NHLBI)（376 个项目；216 784 546 美元）。
脑血管疾病获得 NIH 约 7 亿美元的资金。缺血性中风占 NIH 资助的脑血管项目的大部分，R01 资助是最常见的资助机制。值得注意的是，NHLBI 除了 NINDS 之外还提供了很大一部分资金。
